Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Facebook Inc (FB), Inc (PCLN), Canadian Solar Inc. (CSIQ): Should You Act On These 3 Controversial Upgrades?

It’s never wise to buy on the recommendation of one analyst alone, but you can use the reasons for the call to help make a more informed investment decision. With that said, there were some controversial calls on Monday, but are these analysts right, or does the call create a trap for retail investors?

The upgrades continue to pour in

Facebook Inc (FB)Facebook Inc (NASDAQ:FB) is no stranger to high-profile upgrades following its perception-changing Q2 earnings beat. In the quarter, revenue accelerated from a growth rate of under 40% year-over-year to over 50%. Immediately, due to my feelings that Q2 changed the outlook for the company, I gave it a $50 price target, and was instantly criticized on Twitter.

However, on Monday, the stock hit new 52-week highs after Gene Munster from Piper raised his target from $38 to $46 citing new ad products. Specifically, Munster likes the prospects of new video ads — a service that could more than double Facebook’s current revenue.

Personally, I love this call. At $46, Facebook Inc (NASDAQ:FB) would trade at 18.3 times sales, which would still be significantly less than LinkedIn’s 21 times sales valuation. In my opinion, the long-term outlook for Facebook Inc (NASDAQ:FB) is brightening, with over one million advertisers using the service, and I think Facebook Inc (NASDAQ:FB) is a “Buy.”

A side of caution Inc (NASDAQ:PCLN) ticked higher by 2% on Monday with its price target being hiked 25% to $1,040 by JPMorgan. The firm simply notes expectations for a solid Q2 and more market share gains stemming from its Kayak acquisition. Inc (NASDAQ:PCLN) could very well have a good Q2 and could gain more market share from its competitors. However, as I explain in this article, Priceline is becoming a bit of a valuation concern to me. This is a company that operates with perfection on every level, with an industry best 42% return on equity and 35% operating margin. Inc (NASDAQ:PCLN)’s closest competitor, Expedia, is not even close in terms of efficient investments and margins.

Nonetheless, Inc (NASDAQ:PCLN)’s greatest strengths could become a weakness when trading at 8.25 times sales. Priceline already controls 20% of the entire travel industry, and I am concerned that the company can not grow aggressively without sacrificing margins and its return on investments. Therefore, Inc (NASDAQ:PCLN) might reach $1,040, but I’d definitely view this call on the side of caution.

Too late of a call?

Canadian Solar Inc. (NASDAQ:CSIQ) has produced a one-year 500% gain, yet, Roth is calling for more upside by initiating shares with a “Buy” rating. The firm’s call comes behind the company’s deal to sell five utility-scale solar power plants for $277 million to Concord Green Energy.

The deal strengthens the company’s balance sheet and will allow it to lower its debt-to-assets ratio of 50%. Canadian Solar Inc. (NASDAQ:CSIQ), like other solar companies, had a rough year in 2012 with falling revenue and margins. However, 2013 has produced stability and a boost in margins, which has sparked gains for the stock.

With a market cap of $670 million, Canadian Solar Inc. (NASDAQ:CSIQ) is still cheap at just 0.5 times sales. The company still has a large portfolio of assets that it can divest to become more efficient. As of now, investors appear to like what they see, and I agree that this sell was a good deal for Canadian Solar Inc. (NASDAQ:CSIQ). However with gains of 500% this year, and in a very fragile solar space, I think a “Buy” rating might be a bit too bullish. At this point, it looks as though much of the company’s upside is priced into the stock.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.